RP Bio Inc. (KOSDAQ:314140)
6,950.00
-70.00 (-1.00%)
At close: Sep 19, 2025
RP Bio Revenue
RP Bio had revenue of 35.70B KRW in the quarter ending June 30, 2025, with 11.29% growth. This brings the company's revenue in the last twelve months to 129.09B, down -8.85% year-over-year. In the year 2024, RP Bio had annual revenue of 123.97B, down -17.93%.
Revenue (ttm)
129.09B
Revenue Growth
-8.85%
P/S Ratio
0.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 123.97B | -27.08B | -17.93% |
Dec 31, 2023 | 151.05B | 12.94B | 9.37% |
Dec 31, 2022 | 138.11B | 23.15B | 20.13% |
Dec 31, 2021 | 114.96B | 17.04B | 17.40% |
Dec 31, 2020 | 97.92B | 28.07B | 40.18% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |